European Commission 20 January 2010, Commission Decision of 20/01/2010 declaring a concentration to be compatible with the common market (Case No COMP/M.5611 - AGILENT / VARIAN) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

Also known as

The European Commission, pursuant to Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No 139/2004, conditionally approved Agilent Technologies Inc.'s acquisition of sole control over Varian Inc. by way of share purchase, having identified serious doubts as to compatibility with the common market in four EEA product markets: laboratory GC instruments, micro/portable GC instruments, triple quadrupole GC-MS instruments, and quadrupole ICP-MS instruments. To remedy these concerns, Agilent committed to divesting, on an up-front buyer basis, Agilent's entire global micro/portable GC business and Varian's entire global laboratory GC, triple quadrupole GC-MS, and ICP-MS businesses to one or more independent purchasers approved by the Commission. The Commission found that the proposed remedy package adequately addressed all identified serious doubts and declared the concentration compatible with the common market, subject to full compliance with the divestiture conditions set out in Section B of the annexed Commitments.AI